Back to a subject near and dear to my heart: The increased pressure on the definition of “controlling stockholder” occasioned by Corwin v. KKR Fin. Holdings LLC, 125 A.3d 304 (Del. 2015) and Kahn v. M&F Worldwide Corp., 88 A.3d 635 (Del. 2014) (“MFW”). I’ve posted about this on several prior occasions, and written an essay on the subject, so I would be remiss if I didn’t discuss VC Laster’s new ruling in Voigt v. Metcalf. The facts, as taken from the opinion, are these:
CD&R was a 34.7% blockholder of a publicly-traded corporation called NCI. In earlier years, CD&R had held as much as 68%. CD&R had a stockholder agreement that, among other things, guaranteed it a certain number of board seats – but also guaranteed a certain number of seats for the unaffiliated stockholders – guaranteed that its nominees would have seats on key committees, and gave it blocking/consent rights for various board actions, though none were triggered in this case.
In early 2018, three things happened nearly simultaneously: Metcalf, one of the independent/unaffiliated directors of NCI, was elevated to Chair; CD&R acquired a majority stake in a company called New Ply Gem; and Metcalf proposed that NCI acquire New Ply Gem. To negotiate the deal, Metcalf met with certain NCI directors who were also CD&R representatives/designees.
Eventually, NCI created a Special Committee to evaluate the transaction, and hired Evercore. Well, actually Metcalf hired Evercore before the committee was even formed, and the Committee was told that Evercore had no conflicts – which was untrue, because Evercore was currently working for another CD&R portfolio company. The Committee decided to keep NCI’s counsel, Wachtell.
Evercore recommended that New Ply Gem be acquired with NCI stock valued, post-deal, at roughly 1/3 of NCI’s total equity. This valuation was based on CD&R’s own valuation when it acquired New Ply Gem. CD&R – via the NCI board members – insisted on closer to a 50/50 split. The Committee agreed. The Committee asked for a majority-of-minority voting condition; CD&R refused. When the deal was announced, NCI’s stock price fell, and of the unaffiliated stockholders, only 55% voted in favor.
After the transaction closed, an NCI stockholder brought a derivative lawsuit and, for our purposes, the critical question was whether CD&R was a controlling shareholder. If not, the deal was likely cleansed by the shareholder vote – and even if there were disclosure deficiencies (spoiler: there were), plaintiff would have to establish that the Special Committee was interested/dependent on CD&R to succeed on his claim. But if CD&R was a controlling shareholder, the deal was subject to entire fairness review.
VC Laster concluded that CD&R was a controlling shareholder, and refused to dismiss.
So, what’s notable here?
[More under the jump]
Continue Reading Who’s a Controlling Stockholder: Delaware Strikes Again